Loading company
Kamada Ltd.
KMDA · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
Next earnings: November 9, 2026
$8.70+0.9%Sep 29 close
- 1M
- +4.9%
- 6M
- +9.4%
- 1Y
- +30.1%
- 5Y
- +70.8%
KMDA · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
Next earnings: November 9, 2026
$8.70+0.9%Sep 29 close
Kamada Ltd. is scheduled to report next on November 9, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $54.9M | $44.8M | +22.72% |
| Profit | $9.3M | $7.4M | +25.57% |
| Profit per share | $0.16 | $0.13 | +23.08% |
| Free Cash Flow | $4.8M | $7.5M | -35.90% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“We continue to execute on our plan delivering record-high operational and financial performance during the first half of 2026, with strong double-digit growth in revenues and adjusted EBITDA for both the six-month and second quarter reporting periods,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
The quote and the company description come from the 6-K Kamada Ltd. filed on August 12, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Kamada Ltd. has no earnings call transcript available.